Mom was seen in consultation with her obstetrician the week before delivery where growth restriction and oligohydramnios were noted.
Maternal cytomegalovirus IgG/IgM were negative.
Mother was treated with Aldomet, Labetalol and Hydralazine.
She received Betamethasone at the time of admission on [**8-1**].
Absent end diastolic flow along with a nonreassuring pattern prompted delivery by cesarean section on [**8-6**].
She was brought to the Newborn Intensive Care Unit after visiting briefly with her parents.
On examination, pink, active infant, well saturated and perfused on a ventilator.
HOSPITAL COURSE:  (By systems) Respiratory - [**Known lastname 38492**] was intubated in the Delivery Room and then placed on conventional ventilation upon admission to the Newborn Intensive Care Unit.
She also required sodium bicarbonate around this time for a metabolic acidosis.
[**Known lastname 38492**] remained on low ventilator settings and was extubated to CPAP on day of life #8.
She became increasingly labile on the ventilator requiring increased ventilator settings and a brief trial of high-Fi oscillatory ventilation.
[**Known lastname 38492**] remained intubated on significant settings requiring Combivent, a course of inhaled steroids (from day of life #35 to day of life #71), and diuretics.
She was extubated to continue with positive airway pressure on day of life #63.
She weaned to nasal cannula oxygen on day of life #87.
[**Known lastname 38492**] was started on caffeine citrate around day of life #55 for apnea.
The caffeine was discontinued on day of life #70.
She is currently on nasal cannula oxygen 150 cc of flow with 100% FIO2.
She will continue on a maintenance diuretic regimen of Diuril and QOD Lasix.
She did not require fluid boluses or pressors.
An echocardiogram on [**8-9**] showed a patent ductus arteriosus and she received a course of Indomethacin on day of life #3.
Fluids, electrolytes and nutrition - Intravenous fluids of D10/W at 120 cc/kg/day were started upon admission to the Newborn Intensive Care Unit.
Umbilical venous catheter and an umbilical artery catheter were placed upon admission.
Maximum fluid volume was 150 cc/kg/day.
Enteral feeds were started on day of life #7.
She advanced on enteral feeds to 80 cc/kg but was made NPO on day of life #13 for increased lability on a ventilator, bilious aspirate and abdominal distention.
Reglan and Zantac were started for gastroesophageal reflux on day of life #88.
Gastrointestinal - Phototherapy was started on day of life #1 for a peak bilirubin of 4.5.
Phototherapy was discontinued on day of life #7 with a rebound bilirubin of 2.0 on day of life #8.
Loose stools have improved since her caloric density has been decreased.
She received a platelet transfusion on day of life #3 for a platelet count of 68,000.
She received a total of 4 transfusions of packed red blood cells during her hospitalization.
She was treated for seven days with Ampicillin and Gentamicin for presumed sepsis (leukopenia, thrombocytopenia and severity of illness).
[**Known lastname 38492**] was started on Vancomycin and Gentamicin on day of life #13 for increased lability.
She received a 14 day course of antibiotics for presumed sepsis/pneumonia.
She was again placed on Vancomycin and Gentamicin on day of life #31.
Antibiotics were discontinued after 48 hours.
She has intermittently received Nystatin cream for a monilial diaper rash.
Neurology - [**Known lastname 51821**] head ultrasound on day of life #2, 7 and 37 were all normal.
[**Known lastname 38492**] received regular doses of Fentanyl, Ativan and Morphine while critically ill on the ventilator.
Narcotics and Ativan were finally weaned off by day of life #70.
CONDITION ON DISCHARGE:  [**Known lastname 38492**] is stable on nasal cannula oxygen, feeding well and gaining weight.
CARE/RECOMMENDATIONS: Feeds at discharge - Ad lib demand feeds of 30 cal breast milk or NeoSure.
Reglan .25 mg p.o.
Zantac 5.5 mg p.o.
Vi-Daylin 1 cc p.o.
Ferrous Sulfate 0.5 ml p.o.
Lasix 5.5 mg p.o.
Diuril 55 mg p.o.
K-Cl supplements 4.5 milliequivalents p.o.
Immunizations received - [**Known lastname 38492**] received her hepatitis B vaccines on [**9-22**] and [**10-26**].
She received her first Synagis vaccination on [**11-30**].
Synagis respiratory syncytial virus prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria:  1.
Influenza immunization should be considered annually in the fall for preterm infants with chronic lung disease once they reach six months of age.
Before this age the family and other caregivers should be considered for immunization against influenza to protect the infant.
